These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. IgG surfaces as an important component in mucosal protection. Robert-Guroff M Nat Med; 2000 Feb; 6(2):129-30. PubMed ID: 10655090 [No Abstract] [Full Text] [Related]
8. HIV. Escape artist par excellence. Cohen J Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245 [No Abstract] [Full Text] [Related]
9. CTL ontogeny and viral escape: implications for HIV-1 vaccine design. Yang OO Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041 [No Abstract] [Full Text] [Related]
10. Fc receptor but not complement binding is important in antibody protection against HIV. Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298 [TBL] [Abstract][Full Text] [Related]
11. Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model. Nehete PN; Nehete BP; Manuri P; Hill L; Palmer JL; Sastry KJ Vaccine; 2005 Mar; 23(17-18):2154-9. PubMed ID: 15755586 [TBL] [Abstract][Full Text] [Related]
12. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor. Cohen J Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780 [No Abstract] [Full Text] [Related]
13. Feasibility and cohort development for HIV vaccine trials in Haiti. Deschamps MM; Johnson WD; Pape JW AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S231-3. PubMed ID: 7865308 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccination: where are we now? Rosenberg ES AIDS Clin Care; 2003 Jan; 15(1):1-3. PubMed ID: 12685420 [No Abstract] [Full Text] [Related]
19. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy. Haynes BF; Yasutomi Y; Torres JV; Gardner MB; Langlios AJ; Bolognesi DP; Matthews TJ; Scearce RM; Jones DM; Moody MA Trans Assoc Am Physicians; 1993; 106():33-41. PubMed ID: 8036743 [No Abstract] [Full Text] [Related]
20. [Perspectives for the development of preventive vaccines against HIV/AIDS]. Esparza J Medicina (B Aires); 1998; 58 Suppl 1():57-63. PubMed ID: 9674249 [No Abstract] [Full Text] [Related] [Next] [New Search]